Spherical hearts identified through AI analysis of cardiac MRI may predict AF, cardiomyopathy

Written By :  Medha Baranwal
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-03-31 22:45 GMT   |   Update On 2023-04-01 04:54 GMT

USA: A recent study has found that healthy adults with spherical hearts are 24% more likely to develop atrial fibrillation and 31% more likely to develop atrial fibrillation. The study was published online in the Cell Press Med on March 29, 2023.An artificial intelligence (AI) algorithm revealed that heart roundness seen on cardiac magnetic resonance imaging (MRI) may predict heart failure...

Login or Register to read the full article

USA: A recent study has found that healthy adults with spherical hearts are 24% more likely to develop atrial fibrillation and 31% more likely to develop atrial fibrillation. The study was published online in the Cell Press Med on March 29, 2023.

An artificial intelligence (AI) algorithm revealed that heart roundness seen on cardiac magnetic resonance imaging (MRI) may predict heart failure and atrial fibrillation risk. Researchers identified four loci linked with sphericity at genome-wide significance.

Imaging plays a critical role in heart disease diagnosis and management. Modalities such as MRI and ultrasound allow clinicians to visualize manifestations of heart disease, including a reduction in the heart muscle's pumping strength or enlargement of the heart chambers. Against this background, Milos Vukadinovic, University of California Los Angeles, Los Angeles, CA, USA, and colleagues hypothesized that shape may carry additional information on heart health beyond function and size.

They used artificial intelligence to evaluate >30,000 heart MRIs and revealed that even when function and size are normal, the heart's roundness or sphericity predicts risk for heart conditions. Also, heart roundness is affected by genetic influences.

"Considering heart shape may help improve our ability to identify people at risk for heart disease development," the researchers wrote.

The researchers measured LV (left ventricle) sphericity index (long axis length/short axis length) using deep learning-enabled image segmentation of cardiac MRI data from the UK Biobank. The relationship between left ventricle sphericity and cardiomyopathy was evaluated using genome-wide association studies, Cox analyses, and two-sample Mendelian randomization. Those with abnormal systolic function or LV size were excluded.

The authors reported the following findings:

· In a cohort of 38,897 subjects, a one standard deviation increase in sphericity index is linked with a 47% increased cardiomyopathy incidence (hazard ratio [HR]: 1.47) and a 20% increased incidence of atrial fibrillation (HR: 1.20), independent of clinical factors and traditional MRI measurements.

· Four loci associated with sphericity were identified at genome-wide significance, and Mendelian randomization supports non-ischemic cardiomyopathy as causal for LV sphericity.

According to the authors, the sphericity index may not fully capture phenotypic variation within the LV, as additional features simultaneously impact cardiac function. The study has shown deep learning and advanced imaging analysis to define nontraditional cardiac imaging risk biomarkers using large-scale data.

"We expect that there is a vast search space of potential imaging measurements, and we have only begun to scratch at the surface of disease associations," they concluded.

Reference:

The study "Deep learning-enabled analysis of medical images identifies cardiac sphericity as an early marker of cardiomyopathy and related outcomes" was published in Med.

DOI: https://doi.org/10.1016/j.medj.2023.02.009


Tags:    
Article Source : Med journal

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News